RxDoctor Payments Data

Kristen Barker

Family · Surprise, AZNPI 1811667595

Payments from drug & device makers

$4,220in general payments, 2019–2025

Across 223 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$812
  • Novartis$717
  • Amgen$650
  • Boehringer Ingelheim$310
  • AstraZeneca$307
  • Impulse Dynamics (USA) Inc.$298
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$81219%
  • Food & beverage$3,39480%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,220 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban285$401,848
EntrestoSacubitril/Valsartan176$284,905
XareltoRivaroxaban96$107,601
FarxigaDapagliflozin Propanediol75$90,152
Repatha SureclickEvolocumab34$32,302
JardianceEmpagliflozin21$24,365
Ranolazine ErRanolazine36$4,984
NexlizetBempedoic Acid/Ezetimibe11$4,499
Metoprolol Succinate341$3,854
Ezetimibe142$3,612
ClopidogrelClopidogrel Bisulfate313$3,611
Atorvastatin Calcium301$3,041
Carvedilol302$2,628
Flecainide Acetate49$2,607
Rosuvastatin Calcium226$2,406

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$83$401,848285 claims
NovartisEntresto$717$284,905176 claims
AstraZenecaFarxiga$307$90,15275 claims
Boehringer IngelheimJardiance$310$24,36521 claims
Esperion Therapeutics, Inc.Nexlizet$24$4,49911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.

Other family in Surprise

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →